BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 19082459)

  • 21. Comparison of interleukin-12 with lung cancer and malignant lymphoma undergoing autologous peripheral blood stem cell transplantation.
    Yoshimura C; Nomura S; Kanazawa S; Kuwana M; Yamaguchi K; Fukuhara S
    J Cancer Res Clin Oncol; 2002 Jan; 128(1):29-36. PubMed ID: 11862469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alterations in expression and function of signal-transducing proteins in tumor-associated T and natural killer cells in patients with ovarian carcinoma.
    Lai P; Rabinowich H; Crowley-Nowick PA; Bell MC; Mantovani G; Whiteside TL
    Clin Cancer Res; 1996 Jan; 2(1):161-73. PubMed ID: 9816103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Down-regulation of IL-18 receptor in cancer patients: its clinical significance.
    Kobashi K; Iwagaki H; Yoshino T; Morimoto Y; Kohka H; Kodama M; Nishibori M; Akagi T; Tanaka N
    Anticancer Res; 2001; 21(5):3285-93. PubMed ID: 11848485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired function of innate T lymphocytes and NK cells in the acute phase of ischemic stroke.
    Peterfalvi A; Molnar T; Banati M; Pusch G; Miko E; Bogar L; Pal J; Szereday L; Illes Z
    Cerebrovasc Dis; 2009; 28(5):490-8. PubMed ID: 19752550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unique phenotype of human uterine NK cells and their regulation by endogenous TGF-beta.
    Eriksson M; Meadows SK; Wira CR; Sentman CL
    J Leukoc Biol; 2004 Sep; 76(3):667-75. PubMed ID: 15178706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The emerging role of T cell cytokines in non-small cell lung cancer.
    Neurath MF; Finotto S
    Cytokine Growth Factor Rev; 2012 Dec; 23(6):315-22. PubMed ID: 23022528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Harnessing Natural Killer Cells in Non-Small Cell Lung Cancer.
    Russell É; Conroy MJ; Barr MP
    Cells; 2022 Feb; 11(4):. PubMed ID: 35203256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of natural killer cells in lung cancer.
    Aktaş ON; Öztürk AB; Erman B; Erus S; Tanju S; Dilege Ş
    J Cancer Res Clin Oncol; 2018 Jun; 144(6):997-1003. PubMed ID: 29616326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heat Shock Protein 70 (Hsp70) Peptide Activated Natural Killer (NK) Cells for the Treatment of Patients with Non-Small Cell Lung Cancer (NSCLC) after Radiochemotherapy (RCTx) - From Preclinical Studies to a Clinical Phase II Trial.
    Specht HM; Ahrens N; Blankenstein C; Duell T; Fietkau R; Gaipl US; Günther C; Gunther S; Habl G; Hautmann H; Hautmann M; Huber RM; Molls M; Offner R; Rödel C; Rödel F; Schütz M; Combs SE; Multhoff G
    Front Immunol; 2015; 6():162. PubMed ID: 25926832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natural Killer Cells and Dendritic Cells: Expanding Clinical Relevance in the Non-Small Cell Lung Cancer (NSCLC) Tumor Microenvironment.
    Ahluwalia P; Ahluwalia M; Mondal AK; Sahajpal NS; Kota V; Rojiani MV; Kolhe R
    Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of Lung Cancer Treatment on Cognitive Functioning.
    van de Kamp HJ; Molder MT; Schulkes KJG; Stellingwerf M; van Elden LJR; van Lindert ASR; Hamaker ME
    Clin Lung Cancer; 2020 Mar; 21(2):114-126.e3. PubMed ID: 31839534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunoregulation by resveratrol; implications for normal tissue protection and tumour suppression.
    Lalani AR; Fakhari F; Radgoudarzi S; Rastegar-Pouyani N; Moloudi K; Khodamoradi E; Taeb S; Najafi M
    Clin Exp Pharmacol Physiol; 2023 May; 50(5):353-368. PubMed ID: 36786378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impaired zeta chain expression and IFN-gamma production in peripheral blood T and NK cells of patients with advanced lung cancer.
    Ciszak L; Kosmaczewska A; Werynska B; Szteblich A; Jankowska R; Frydecka I
    Oncol Rep; 2009 Jan; 21(1):173-84. PubMed ID: 19082459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NK cell-based therapeutics for lung cancer.
    Pockley AG; Vaupel P; Multhoff G
    Expert Opin Biol Ther; 2020 Jan; 20(1):23-33. PubMed ID: 31714156
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.